[go: up one dir, main page]

AU3923293A - Human monoclonal antibodies and methods for human monoclonal antibody production - Google Patents

Human monoclonal antibodies and methods for human monoclonal antibody production

Info

Publication number
AU3923293A
AU3923293A AU39232/93A AU3923293A AU3923293A AU 3923293 A AU3923293 A AU 3923293A AU 39232/93 A AU39232/93 A AU 39232/93A AU 3923293 A AU3923293 A AU 3923293A AU 3923293 A AU3923293 A AU 3923293A
Authority
AU
Australia
Prior art keywords
human monoclonal
methods
antibody production
monoclonal antibody
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39232/93A
Inventor
Robert Blake Whitaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNET
Original Assignee
IMMUNET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNET filed Critical IMMUNET
Publication of AU3923293A publication Critical patent/AU3923293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/166—Animal cells resulting from interspecies fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU39232/93A 1992-03-20 1993-03-18 Human monoclonal antibodies and methods for human monoclonal antibody production Abandoned AU3923293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85608892A 1992-03-20 1992-03-20
US856088 1992-03-20

Publications (1)

Publication Number Publication Date
AU3923293A true AU3923293A (en) 1993-10-21

Family

ID=25322828

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39232/93A Abandoned AU3923293A (en) 1992-03-20 1993-03-18 Human monoclonal antibodies and methods for human monoclonal antibody production

Country Status (4)

Country Link
EP (1) EP0651819A1 (en)
JP (1) JPH07507923A (en)
AU (1) AU3923293A (en)
WO (1) WO1993019197A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
US5811524A (en) 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
ZA966075B (en) * 1995-07-27 1998-01-19 Genentech Inc Protein formulation.
WO1997010004A1 (en) * 1995-09-13 1997-03-20 Genentech, Inc. Methods for treatment of interstitial cystitis
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
UY30994A1 (en) * 2007-04-02 2008-11-28 Amgen Fremont Inc ANTI-IGE ANTIBODIES
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716111A (en) * 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US4693966A (en) * 1983-03-11 1987-09-15 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies from lymphocytes of patients with malignant melanoma
HUT62803A (en) * 1990-05-22 1993-06-28 Univ California Process for producing antigen-specific, high affinity human monoclonal antibody

Also Published As

Publication number Publication date
EP0651819A1 (en) 1995-05-10
WO1993019197A1 (en) 1993-09-30
JPH07507923A (en) 1995-09-07

Similar Documents

Publication Publication Date Title
AU3379193A (en) Antigen binding proteins and methods for their production
AU1209495A (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
EP0539970A3 (en) Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby
AU2782789A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1289795A (en) Monoclonal antibodies specific for human interleukin-5
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU4618193A (en) Humanized antibodies
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU1241795A (en) Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3330689A (en) Monoclonal antibodies
HUT63205A (en) Process for producing monoclonal antibodies and their fragments
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
AU8407091A (en) Mouse/human heterohybrid cell line el41 and methods for the production of human monoclonal antibodies
IL118069A (en) Monoclonal antibody reactive to human CETP and assay method for human CETP
EP0285511A3 (en) Monoclonal antibodies and their uses
AU4274293A (en) Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
AU8598791A (en) A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins
AU6725190A (en) Anti-platelet monoclonal antibody
AU7014294A (en) Human monoclonal antibodies and processes and materials for making such antibodies
AU2383288A (en) Human anti-rh(d) monoclonal antibodies
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU9143991A (en) Monoclonal antibody op-g2 and method of use